Table 2.

Comparison between multiple sclerosis patients subgroups: very minor-minor NBDs vs moderate-severe NBDs

MS patients (n = 1100)	NBDs < 10 (n = 940, 83%)	NBDs ≥ 10 (n = 160, 17%)	p
Age, mean years (SD)	43.7 (12.5)	47.2 (11.0)	0.0006b
Sex, M/W Number (%)	325 (35%) /615 (65%)	109 (68%)/51 (32%)	n.sa
Disease duration, mean years (SD)	10.9 (8.9)	12.7 (7.7)	0.0002b
EDSS, median (range)	2 0–9	4 (0–9)	< 0.0001b
Phenotype RR/SP/PP Number (%)	819 (87%)/83 (9%)/38 (4%)	108 (68%)/35 (22%)/17 (10%)	< 0.0001a
IPSS mean, median (SD, range)	8.9, 6 (8.9; 0–35)	21.5, 23 (9.9; 0–35)	< 0.0001b

Bonferroni Method Correction

MS multiple sclerosis, NBDs Neurogenic bowel dysfunction score, SD standard deviation, M men, W women, EDSS Expanded Disability Status Scale, RR relapsing remitting, SP secondary progressive, PP primary progressive, IPSS International Prostatic Symptoms Score

^aFisher test

^bWilcoxon rank-sum test (Mann–Whitney)